Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Tranexamic Acid in Caesarean Delivery
NCT05759156Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Mar 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Dow University of Health Sciences. Primary endpoints: Occurrence of postpartum haemorrhage at 2 days and Obstetrics quality of recovery score at 2 days. Started Mar 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05759156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05759156.